Samlyn Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-319,432	Closed	-$36.4M	–	127
2022 Q4	$36.4M	Sell	319,432 -1,242,001	-80%	-$103M	0.71%	49
2022 Q3	$96.6M	Sell	1,561,433 -1,158,049	-43%	-$80.9M	1.8%	19
2022 Q2	$217M	Buy	2,719,482 +265,447	+11%	+$25.1M	4.33%	5
2022 Q1	$258M	Buy	2,454,035 +789,021	+47%	+$76.9M	3.71%	4
2021 Q4	$179M	Buy	1,665,014 +521,934	+46%	+$56.9M	2.48%	9
2021 Q3	$125M	Sell	1,143,080 -77,042	-6%	-$8M	1.68%	19
2021 Q2	$114M	Buy	1,220,122 +191,922	+19%	+$17.7M	1.68%	19
2021 Q1	$94.6M	Sell	1,028,200 -216,112	-17%	-$18.2M	1.31%	30
2020 Q4	$91M	Buy	1,244,312 +525,296	+73%	+$39M	1.3%	23
2020 Q3	$55.9M	Sell	719,016 -836,600	-54%	-$57.6M	1.01%	30
2020 Q2	$86.5M	Sell	1,555,616 -108,688	-7%	-$4.65M	1.6%	19
2020 Q1	$49.3M	Buy	1,664,304 +486,771	+41%	+$16.5M	1.24%	32
2019 Q4	$42.6M	Buy	1,177,533 +142,700	+14%	+$4.38M	0.89%	40
2019 Q3	$28.2M	Buy	1,034,833 +271,383	+36%	+$7.02M	0.68%	55
2019 Q2	$18.4M	Buy	763,450 +475,457	+165%	+$12.1M	0.39%	74
2019 Q1	$7.61M	Buy	+287,993	New	+$6.82M	0.18%	86
2016 Q4	–	Sell	-728,700	Closed	-$13.2M	–	161
2016 Q3	$13.2M	Buy	+728,700	New	+$14.2M	0.31%	91